Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, today announced that it has granted inducement stock options to purchase an aggregate of 86,720 shares of its common stock to 5 new employees. these inducement stock options have a grant date of january 31, 2021, and were granted as inducements material to t
BIOC Ratings Summary
BIOC Quant Ranking